In relation to the medication, patients with CHD were more frequently under antiplatelet therapy, oral anticoagulants, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), calcium channel blockers, and loop diuretics than patients in the control group (p < 0.05). The gene discussed is ACE; the disease is coronary artery disorder.